Table 2. Correlation between clinicopathological factors and NPM, TFF3 and TACC1 expressions.

Clinicopathological factors	NPM		P-value	TFF3		P-value	TACC1		P-value
	Positive	Negative		Positive	Negative		Positive	Negative
	N = 67	N = 75		N = 63	N = 79		N = 70	N = 72
Age
≤60	34	35	P>0.05	27	42	P>0.05	31	38	P>0.05
>60	33	40		36	37		39	34
Gender
Male	48	45	P>0.05	38	55	P>0.05	36	57	P<0.05
Female	19	30		25	24		34	15
Tumor diameter
≤50 mm (small)	47	45	P>0.05	39	53	P>0.05	45	47	P>0.05
>51 mm (large)	20	30		24	26		25	25
Tumor depth
Early cancer (T**1)	12	8	P>0.05	10	10	P>0.05	13	7	P>0.05
Advanced cancer (T2–T4)	55	67		53	69		57	65
Histologic type
Well moderately	8	19	P<0.05	6	21	P<0.05	7	20	P<0.05
Poor, others	59	56		57	58		63	52
Peritoneal metastasis
Negative	61	73	P>0.05	58	76	P>0.05	66	68	P>0.05
Positive	6	2		5	3		4	4
Venous invasion
Negative	65	69	P>0.05	60	74	P>0.05	63	71	P<0.05
Positive	2	6		3	5		7	1
Lymph node metastasis
Negative	26	38	P>0.05	22	42	P<0.05	29	35	P>0.05
Positive	41	37		41	37		41	37
Hepatic metastasis
Negative	60	74	P<0.05	59	75	P>0.05	64	70	P>0.05
Positive	7	1		4	4		6	2
Recurrence
Negative	56	71	P<0.05	55	72	P>0.05	61	66	P>0.05
Positive	11	4		8	7		9	6

P<0.05 Statistically significant;

T: tumor size.